ECM
CHE icon

Everence Capital Management’s Chemed CHE Stock Holding History

Everence Capital Management’s Portfolio CHE Stock Details CHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-1,470
Closed -$269K – 375
2017
Q1 		$269K Buy
+1,470
New +$256K 0.07% 291

Other funds holding CHE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
GI
GAMCO Investors Greenwich, Connecticut $10.2B AUM 30.27% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VBA
Van Berkom & Associates Montreal, Quebec, Canada $3.08B AUM 12.07% 1-Year Est. Return

Everence Capital Management's CHE Position: Q2 2017 in Review

Everence Capital Management sold out of Chemed (CHE) in Q2 2017, closing a stake of 1,470 shares — an estimated $269K sold.

Everence Capital Management first reported a position in CHE in Q1 2017 and held it in 1 quarter. The position peaked at $269K in Q1 2017. 272 funds tracked by Wall St. Rank hold CHE as of Q2 2017.

  • Everence Capital Management reported no remaining Chemed position as of Q2 2017 after selling out during the quarter.
  • Everence Capital Management sold 1,470 Chemed shares in Q2 2017, an estimated $269K.
  • Everence Capital Management first reported a position in Chemed in Q1 2017 and held it in 1 quarter.
  • Everence Capital Management's Chemed position peaked at $269K in Q1 2017.
  • 272 funds tracked by Wall St. Rank held Chemed as of Q2 2017.

Based on Everence Capital Management's 13F filing for Q2 2017, filed 4 Aug 2017.